Companies / Clearside Biomedical, Inc.
Clearside Biomedical, Inc.
CLSDCIK 1539029
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Whitmore Bradford T 10% owner | Sell Open-market sale | Common Stock | $1.47M | -213K -8.11% | 2,415,056 | medium |
| Jan 6, 2021 | Whitmore Bradford T 10% owner | Buy Open-market buy | Common Stock | $1000.0K | +351K +11.03% | 3,529,845 | high |
| Aug 31, 2021 | Whitmore Bradford T 10% owner | Sell Open-market sale | Common Stock | $749.1K | -108K -3.94% | 2,628,259 | medium |
| Aug 30, 2021 | Whitmore Bradford T 10% owner | Sell Open-market sale | Common Stock | $702.1K | -99K -3.51% | 2,735,941 | medium |
| Feb 7, 2024 | Whitmore Bradford T 10% owner | Buy Open-market buy | Common Stock | $600.0K | +444K +10.97% | 4,495,034 | high |
| Feb 10, 2021 | Thorp Clay Director | Sell Open-market sale | Common Stock | $145.6K | -33K -0.95% | 3,433,521 | medium |
| Feb 10, 2021 | Thorp Clay Director | Sell Open-market sale | Common Stock | $145.6K | -33K -0.66% | 4,951,547 | medium |
| Apr 18, 2024 | Gibney Anthony S Director | Buy Open-market buy | Common Stock | $121.3K | +93K +1390.31% | 100,000 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CLSD | common | 185063104 |